Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.74 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.74 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.74 |
| ▸ | PPARG | P37231 | 7/20 | 0.74 |
| ▸ | PPARD | Q03181 | 7/20 | 0.74 |
| ▸ | PPARA | Q07869 | 7/20 | 0.74 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.74 |
| ▸ | TSHR | P16473 | 4/20 | 0.74 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.74 |
| ▸ | TLR2 | O60603 | 2/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.74 |
| ▸ | FABP4 | P15090 | 2/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.74 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.74 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.74 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | ESR1 | P03372 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16023553 | 1.00 | FFAR4 (0.74) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL516197 | 1.00 | FFAR4 (0.74) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL2354538 | 1.00 | FFAR4 (0.74) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL2600375 | 1.00 | FFAR4 (0.74) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL16131158 | 1.00 | FFAR4 (0.74) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL13069503 | 1.00 | FFAR4 (0.74) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL23128413 | 1.00 | FFAR4 (0.74) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL10448425 | 1.00 | FFAR4 (0.74) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL19076153 | 1.00 | FFAR4 (0.74) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL14213379 | 1.00 | FFAR4 (0.74) | FFAR4FFAR1GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117794983-A | High molecular weight polyesteramides | 首诺公司 | 2024-03-29 | — | — | CN | claimed |
| CN-111655806-B | Polyester amide, process for producing the same, and polyester amide composition | 伊士曼化工公司 | 2023-12-05 | — | — | CN | claimed |
| CN-111630122-B | Novel polyesteramide, process for producing the same and polyesteramide composition | 伊士曼化工公司 | 2023-07-28 | — | — | CN | claimed |
| CN-117794983-A | High molecular weight polyesteramides | 首诺公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-111655806-B | Polyester amide, process for producing the same, and polyester amide composition | 伊士曼化工公司 | 2023-12-05 | — | — | CN | disclosed |
| CN-111630122-B | Novel polyesteramide, process for producing the same and polyesteramide composition | 伊士曼化工公司 | 2023-07-28 | — | — | CN | disclosed |
| US-20180148625-A1 | Invert Emulsion Drilling Fluids with Fatty Acid and Fatty Amine Rheology Modifiers | SAUDI ARABIAN OIL COMPANY (SA) | 2018-05-31 | — | — | US | disclosed |
| US-20180148626-A1 | Invert Emulsion Drilling Fluids with Fatty Acid and Fatty Diol Rheology Modifiers | SAUDI ARABIAN OIL COMPANY (SA) | 2018-05-31 | — | — | US | disclosed |
| EP-2322512-B1 | Alkylated benzimidazolone compounds and self-assembled nanostructures generated therefrom | XEROX CORP (US) | 2015-10-21 | — | — | EP | disclosed |
| US-9017701-B2 | Organogel compositions comprising alkylated benzimidazolones | XEROX CORPORATION (US) | 2015-04-28 | — | — | US | disclosed |
| CN-102040560-B | Self-assembled nanostructures | XEROX CORP | 2015-01-28 | — | — | CN | disclosed |
| US-20130123375-A1 | Organogel Compositions Comprising Alkylated Benzimidazolones | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2013-05-16 | — | — | US | disclosed |
| US-8362270-B2 | Self-assembled nanostructures | XEROX CORPORATION (US) | 2013-01-29 | — | — | US | disclosed |
| US-20110282072-A1 | SELF-ASSEMBLED NANOSTRUCTURES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2011-11-17 | — | — | US | disclosed |
| EP-2322512-A1 | Alkylated benzimidazolone compounds and self-assembled nanostructures generated therefrom | Xerox Corporation (US) | 2011-05-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282072-A1 | SELF-ASSEMBLED NANOSTRUCTURES | RB1, CNKSR1, RBBP4 | FFAR4 2903/4885FFAR1 2841/4885GPR84 2907/4885 |
| US-20130123375-A1 | Organogel Compositions Comprising Alkylated Benzimidazolones | BLM, SBK3, CHEK2 | FFAR4 4329/4885FFAR1 4760/4885GPR84 3672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.